World's Best Scientists 2026 revealed!
Mario Boccadoro

Mario Boccadoro

D-Index & Metrics

Medicine

D-Index
110
Citations
59022
World Ranking
5454
National Ranking
172

Overview

Mario Boccadoro is affiliated with the University of Turin in Italy. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant emphasis on Hematology, Molecular Biology, and Oncology. Their scholarly output also covers subfields including Genetics and Pathology and Forensic Medicine.

The scientist's work addresses multiple topics in biomedical research. Key areas include Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Cancer Treatment and Pharmacology, Chronic Lymphocytic Leukemia Research, Cancer therapeutics and mechanisms, and Chronic Myeloid Leukemia Treatments.

Frequent publication venues where Mario Boccadoro's research appears include Blood, Clinical Lymphoma Myeloma & Leukemia, HemaSphere, Journal of Clinical Oncology, and Haematologica.

Several coauthors have collaborated extensively with Mario Boccadoro, reflecting a collaborative approach in the research community. These frequent collaborators are Pieter Sonneveld, Francesca Gay, Michèle Cavo, Roman Hájek, and Meletios Α. Dimopoulos.

Among recent papers authored or coauthored by Mario Boccadoro are the following:

  • Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma, 2023, New England Journal of Medicine
  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, 2020, The Lancet Haematology
  • Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project, 2022, Journal of Clinical Oncology
  • Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial, 2021, The Lancet Oncology

Best Publications

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

    Antonio Palumbo;Sara Bringhen;Tommaso Caravita;Emanuela Merla

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Autologous transplantation and maintenance therapy in multiple myeloma

    Antonio Palumbo;Federica Cavallo;Francesco Di Raimondo

  • MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

    Flavia Pichiorri;Sung Suk Suh;Marco Ladetto;Michael Kuehl

  • Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.

    Paul Gerard Richardson;Pieter Sonneveld;Michael Schuster;David Irwin

  • A comparison of allografting with autografting for newly diagnosed myeloma.

    Benedetto Bruno;Marcello Rotta;Francesca Patriarca;Nicola Mordini

  • Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

    Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

  • Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

    Antonio Palumbo;Sara Bringhen;Davide Rossi;Maide Cavalli

  • Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

    M A Dimopoulos;P Moreau;E Terpos;M V Mateos

  • Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

    Meletios Dimopoulos;Robert Kyle;Jean Paul Fermand;S. Vincent Rajkumar

  • Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

    Sara Bringhen;Alessandra Larocca;Davide Rossi;Maide Cavalli

  • Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

    Antonio Palumbo;Sara Bringhen;Anna M. Liberati;Tommaso Caravita

  • Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

    Mandelli F;Avvisati G;Amadori S;Boccadoro M

  • Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)

    Antonio Palumbo;Sara Bringhen;Heinz Ludwig;Meletios A. Dimopoulos

Frequent Co-Authors

Antonio Palumbo
Antonio Palumbo University of Turin
Maria Teresa Petrucci
Maria Teresa Petrucci Sapienza University of Rome
Michele Cavo
Michele Cavo University of Bologna
Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro
Paolo Corradini
Paolo Corradini University of Milan
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Massimo Massaia
Massimo Massaia University of Turin
Federica Cavallo
Federica Cavallo University of Turin
Roman Hájek
Roman Hájek University of Ostrava
Francesco Di Raimondo
Francesco Di Raimondo University of Catania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in alternative healthcare careers or flexible study options, several online degrees and pathways can support your goals. Many students explore nursing programs with high acceptance rates for quicker entry into the field, offering a practical route toward becoming a registered nurse. Additionally, there are best nursing schools with no TEAS or HESI exams requirement, making the admission process even more accessible for those who prefer not to take standardized tests.

If you prefer working in medical administration, accredited programs in healthcare management can be completed online, with the best accelerated healthcare administration degree programs online providing a fast track to leadership roles in clinics, hospitals, or private practices. Another in-demand choice is medical billing and coding, where best accredited medical billing and coding schools online with financial aid allow students to secure certification affordably and efficiently.

These options are ideal for students seeking flexible schedules, quicker pathways into healthcare, or alternate careers beyond traditional medical school. Exploring these online degrees can open various rewarding roles within the ever-growing healthcare sector.

Best Scientists Citing Mario Boccadoro

Trending Scientists

Recently Published Articles